about
Project of the countrywide data collecting system for neonatal hearing screening programme in Poland.Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategyMalonylcarnitine in newborns with non-syndromic cleft lip with or without cleft palate.Hepcidin and Iron Metabolism in Pregnancy: Correlation with Smoking and Birth Weight and Length.Propionylcarnitine and methionine concentrations in newborns with hypospadias.Congenital hypothyroidism - Polish recommendations for therapy, treatment monitoring, and screening tests in special categories of neonates with increased risk of hypothyroidism.Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.Evaluation of somatic development in adult patients with previously undiagnosed and/or untreated phenylketonuria.Whole blood citrulline concentrations in newborns with non-syndromic oral clefts--a preliminary report.Iodine status of pregnant women from central Poland ten years after introduction of iodine prophylaxis programme.[The effect of tobacco smoking on nitric oxide serum concentration in pregnant women and umbilical cord blood].Neonatal hypothyroid screening in monitoring of iodine deficiency and iodine supplementation in Poland.Molecular genetics of PKU in Poland and potential impact of mutations on BH4 responsiveness.Additional risk factor for the development of ALL.[The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].Effect of tobacco smoking on the maternal and fetal adipokine axis in relation to newborn birth weight and length.[Risk factors for atherosclerosis in obese children aged 6-12 years].Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.[Umbilical cord serum hepcidin levels and maternal smoking during pregnancy].[The effect of tobacco smoking on serum concentration of selected angiogenic factors and somatomedin C in pregnant women and umbilical cord blood].3-Methylglutaconic aciduria, a frequent but underrecognized finding in carbamoyl phosphate synthetase I deficiencyUrgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening[Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience][The impact of iodine prophylaxis programme on thyroid gland morphology and function in children and adolescents from the Mazowieckie Voivodship][Maple Syrup Urine Disease in a newborn infant]Serum concentration of adipocytokines in prepubertal vegetarian and omnivorous children[Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria]Can leptin and soluble leptin receptor concentrations be used in assessing the efficacy of weight reduction programme in prepubertal obese children? Preliminary report[Whole blood citrulline levels in patients with coeliac disease][The effect of tobacco smoking during pregnancy on birth mass on the basis of population studies--preliminary results][Effect of weight reduction programme on C-peptide concentration and lipid profile in obese children aged 4 to 10 years]Whole blood propionylcarnitine in newborns with orofacial cleft[Cortisol concentration, hypotension and treatment of cardiovascular insufficiency in the first days of life of very preterm newborns - preliminary report][Effect of vitamin D supplementation on serum 25-hydroxyvitamin D and bone turnover markers concentrations in vegetarian children][Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]Measurement of functional independence level and falls-risk in individuals with undiagnosed phenylketonuriaHyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring[Adipokines, body composition and bone mineral density in underweight children][Screening in specific categories of neonates exposed to congenital hypothyroidism]Iodine supplementation during pregnancy of hypothyroid women treated with L-thyroxine neither influences neonatal TSH nor prevents decrease in maternal free thyroid hormone concentrations in second and third trimesters
P50
Q30650204-0EEB08F1-CE1C-44D9-8D95-8C46A96E8D0AQ34293992-7F05658D-81BC-477B-91E8-9220DA46983DQ36330824-FCE7B9FE-5379-46EE-A163-20327D58C8A8Q37156144-34A8BF3C-1E69-4E24-8823-25F3B836D823Q37682437-7BB04A5E-4E8E-4035-80DC-80A45CEA9357Q39201653-8A07F7C5-9F91-41FA-872A-E0210A56EEFDQ40908913-48FA8EE6-EB32-427E-9322-AF8747831D56Q41937231-B0AC584A-29F4-4501-8EE9-429DE1E6D59FQ42163451-8602AF1E-609C-44FC-8879-14F7F5F17C38Q42793483-0D9E7328-9DA0-4DCE-9BDC-7DB2140327ACQ43123991-D7BED6DD-EC19-4E3B-ACE4-21FA29D5C42AQ44450661-256C49B9-71C3-4BE1-9410-EAD1B0058A0CQ44670656-71FA401D-AB64-4E98-BCED-C1CF88B48F5DQ45995088-FE2BC113-3E25-4281-A172-055909A63A75Q46135436-C246B913-A0F5-4B83-B3EF-E8631A09C188Q47192477-AAA96A29-B352-457C-BF2E-0D71FE5271C7Q50096600-63202716-4CE7-434D-9568-8575FC4C09F3Q53438013-BBA8C9C1-14CD-455C-83D7-87E997707A98Q53656391-42E7ABAC-8C4B-4A50-A6D5-ED63BE8635F1Q54313501-CD1EDDEC-329B-4A92-8457-28EA919CC1B2Q57666681-2CC49720-C485-4515-8BA1-42BAFC507675Q61763844-04D118F0-0E91-48F1-9A5E-878F5BFC1D27Q74054295-D8A173FD-BB4D-438A-901B-D156EE1E24B4Q74066449-BB74A918-6096-4514-99C3-D90DD59ACB48Q81509658-3685F829-DA69-482F-99DD-76015D43E0EFQ82067513-D954AEAD-519B-4BD6-83EF-475D19A688FFQ82227005-37831B4F-4A3C-4364-80AA-BDF5BA767BCBQ82545058-A20A6745-8CBB-46BF-BB0D-7EFFAD1E7523Q83366072-90945015-BD09-4748-A9CD-0D575C63F7B3Q83501296-896CF4CA-4DC0-4C49-A26B-E33006A8B48FQ83776015-6501633A-B715-4123-A1E4-06E337B267FCQ83796172-E5DB0F97-4136-4AA6-AA76-636C9359CDA8Q83917791-D891A61B-238A-4B97-8196-363D9CCCDAC4Q84334980-61824535-8D00-43EE-A447-73E0CA9DB93DQ84965494-DFD7E745-78E7-4CA3-85DC-D5EE1D86E198Q85058803-F66EF479-704B-49AB-B1C5-4C92CC29893AQ85245543-94F9CDCB-ABDF-4901-9ED7-52D1D6458A6EQ85907976-0297B48C-1591-4248-877F-97C8D6B93115Q87614737-985087CC-B752-462F-8EEA-788CC30EE68EQ87840416-6A585699-AE1E-4163-AAC2-96004652CACA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mariusz Oltarzewski
@ast
Mariusz Oltarzewski
@en
Mariusz Oltarzewski
@es
Mariusz Oltarzewski
@nl
type
label
Mariusz Oltarzewski
@ast
Mariusz Oltarzewski
@en
Mariusz Oltarzewski
@es
Mariusz Oltarzewski
@nl
prefLabel
Mariusz Oltarzewski
@ast
Mariusz Oltarzewski
@en
Mariusz Oltarzewski
@es
Mariusz Oltarzewski
@nl
P106
P1153
7801551389
P31
P496
0000-0002-3353-723X